Ilia I. Ouspenski

Array ( [id] => 5330666 [patent_doc_number] => 20090111143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'Methods and Compositions for Mammalian Cell Lines for Transfection and Protein Expression in Serum-Free Medium' [patent_app_type] => utility [patent_app_number] => 11/877728 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20138 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111143.pdf [firstpage_image] =>[orig_patent_app_number] => 11877728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879268 [patent_doc_number] => 20080152651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Novel polypeptides involved in immune response' [patent_app_type] => utility [patent_app_number] => 11/978069 [patent_app_country] => US [patent_app_date] => 2007-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 28812 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152651.pdf [firstpage_image] =>[orig_patent_app_number] => 11978069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898899 [patent_doc_number] => 20080118513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Treatment of immune disorders with antibodies to costimulating polypeptide of T cells' [patent_app_type] => utility [patent_app_number] => 11/977335 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7484 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118513.pdf [firstpage_image] =>[orig_patent_app_number] => 11977335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271008 [patent_doc_number] => 20090074784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Treatment of chronic viral diseases with antibodies to costimulating polypeptide of T cells' [patent_app_type] => utility [patent_app_number] => 11/977342 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7485 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20090074784.pdf [firstpage_image] =>[orig_patent_app_number] => 11977342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778285 [patent_doc_number] => 20080286283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Treatment of cancer with antibodies to costimulating polypeptide of T cells' [patent_app_type] => utility [patent_app_number] => 11/977334 [patent_app_country] => US [patent_app_date] => 2007-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7485 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286283.pdf [firstpage_image] =>[orig_patent_app_number] => 11977334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7597508 [patent_doc_number] => 07619069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Antibodies to TGF-beta 1' [patent_app_type] => utility [patent_app_number] => 11/874952 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11569 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/619/07619069.pdf [firstpage_image] =>[orig_patent_app_number] => 11874952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415903 [patent_doc_number] => 20090041790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Methods for treating cardiovascular disease using a soluble CTLA4 molecule' [patent_app_type] => utility [patent_app_number] => 11/975659 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 103 [patent_no_of_words] => 51227 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041790.pdf [firstpage_image] =>[orig_patent_app_number] => 11975659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262781 [patent_doc_number] => 20100297146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'IMMUNE SYSTEM PROGRAMMING THROUGH B7-DC' [patent_app_type] => utility [patent_app_number] => 12/444820 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 23065 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297146.pdf [firstpage_image] =>[orig_patent_app_number] => 12444820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860614 [patent_doc_number] => 20080269464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING LYMPHOCTE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/875537 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 36482 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269464.pdf [firstpage_image] =>[orig_patent_app_number] => 11875537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908970 [patent_doc_number] => 08481029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Human immune therapies using a CD27 agonist alone or in combination with other immune modulators' [patent_app_type] => utility [patent_app_number] => 12/446322 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 15028 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908970 [patent_doc_number] => 08481029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Human immune therapies using a CD27 agonist alone or in combination with other immune modulators' [patent_app_type] => utility [patent_app_number] => 12/446322 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 15028 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12446322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760192 [patent_doc_number] => 20080312418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Antibody Specific for Human 4-1BB Receptor' [patent_app_type] => utility [patent_app_number] => 11/873784 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6922 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312418.pdf [firstpage_image] =>[orig_patent_app_number] => 11873784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12703 [patent_doc_number] => 07807156 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-10-05 [patent_title] => 'Methods of treating OX40 mediated recall immune responses' [patent_app_type] => utility [patent_app_number] => 11/873149 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16605 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807156.pdf [firstpage_image] =>[orig_patent_app_number] => 11873149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939400 [patent_doc_number] => 20080076719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'IMMUNOREGULATORY COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/859265 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11298 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076719.pdf [firstpage_image] =>[orig_patent_app_number] => 11859265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367152 [patent_doc_number] => 20090304711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Combinatorial Therapy of Cancer and Infectious Diseases with Anti-B7-H1 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/441996 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15916 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304711.pdf [firstpage_image] =>[orig_patent_app_number] => 12441996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 174005 [patent_doc_number] => 07659384 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Polynucleotides encoding fully human antibodies against human 4-1BB' [patent_app_type] => utility [patent_app_number] => 11/903106 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 39 [patent_no_of_words] => 11856 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659384.pdf [firstpage_image] =>[orig_patent_app_number] => 11903106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4704580 [patent_doc_number] => 20080064104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'ANTAGONISTS AND AGONISTS OF LDCAM AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/852123 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 47268 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064104.pdf [firstpage_image] =>[orig_patent_app_number] => 11852123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938402 [patent_doc_number] => 20080075721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'METHOD OF TREATING FIBROSIS' [patent_app_type] => utility [patent_app_number] => 11/851166 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17852 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075721.pdf [firstpage_image] =>[orig_patent_app_number] => 11851166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515688 [patent_doc_number] => 20090215995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'B-7 related nucleic acids and polypeptides useful for immunomodulation' [patent_app_type] => utility [patent_app_number] => 11/900026 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 43549 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215995.pdf [firstpage_image] =>[orig_patent_app_number] => 11900026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758891 [patent_doc_number] => 20080311117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Antibodies against PD-1 and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/893989 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14519 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311117.pdf [firstpage_image] =>[orig_patent_app_number] => 11893989 [rel_patent_id] =>[rel_patent_doc_number] =>)